Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Chitinase dependent control of protozoan cyst burden in the brain.

Nance JP, Vannella KM, Worth D, David C, Carter D, Noor S, Hubeau C, Fitz L, Lane TE, Wynn TA, Wilson EH.

PLoS Pathog. 2012;8(11):e1002990. doi: 10.1371/journal.ppat.1002990. Epub 2012 Nov 29.

2.
3.

Detection of a novel 40,000 MW excretory Toxoplasma gondii antigen by murine Th1 clone which induces toxoplasmacidal activity when exposed to infected macrophages.

Reichmann G, Stachelhaus S, Meisel R, Mévélec MN, Dubremetz JF, Dlugonska H, Fischer HG.

Immunology. 1997 Oct;92(2):284-9.

4.

DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.

Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ.

Vaccine. 2013 Dec 16;31(52):6225-31. doi: 10.1016/j.vaccine.2013.10.034. Epub 2013 Oct 31.

PMID:
24183979
5.

Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice.

Chen J, Li ZY, Huang SY, Petersen E, Song HQ, Zhou DH, Zhu XQ.

BMC Infect Dis. 2014 Sep 6;14:487. doi: 10.1186/1471-2334-14-487.

6.
7.

Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica.

Miller CM, Smith NC, Ikin RJ, Boulter NR, Dalton JP, Donnelly S.

PLoS One. 2009 May 25;4(5):e5692. doi: 10.1371/journal.pone.0005692.

9.
11.

Protective Th1 immune responses against chronic toxoplasmosis induced by a protein-protein vaccine combination but not by its DNA-protein counterpart.

Jongert E, Verhelst D, Abady M, Petersen E, Gargano N.

Vaccine. 2008 Sep 26;26(41):5289-95. doi: 10.1016/j.vaccine.2008.07.032. Epub 2008 Aug 27.

PMID:
18675872
12.

Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.

Khan IA, Hakak R, Eberle K, Sayles P, Weiss LM, Urban JF Jr.

Infect Immun. 2008 Mar;76(3):1305-13. doi: 10.1128/IAI.01236-07. Epub 2008 Jan 14.

13.

Forward genetics screens using macrophages to identify Toxoplasma gondii genes important for resistance to IFN-γ-dependent cell autonomous immunity.

Walwyn O, Skariah S, Lynch B, Kim N, Ueda Y, Vohora N, Choe J, Mordue DG.

J Vis Exp. 2015 Mar 12;(97). doi: 10.3791/52556.

15.

CCR7-dependent immunity during acute Toxoplasma gondii infection.

Noor S, Habashy AS, Nance JP, Clark RT, Nemati K, Carson MJ, Wilson EH.

Infect Immun. 2010 May;78(5):2257-63. doi: 10.1128/IAI.01314-09. Epub 2010 Mar 1.

16.

Effect of alveolar macrophages on Toxoplasma gondii.

Ryning FW, Remington JS.

Infect Immun. 1977 Dec;18(3):746-53.

17.

Patterns of Toxoplasma gondii cyst distribution in the forebrain associate with individual variation in predator odor avoidance and anxiety-related behavior in male Long-Evans rats.

Evans AK, Strassmann PS, Lee IP, Sapolsky RM.

Brain Behav Immun. 2014 Mar;37:122-33. doi: 10.1016/j.bbi.2013.11.012. Epub 2013 Nov 21.

18.

Induction and regulation of host cell-mediated immunity by Toxoplasma gondii.

Sher A, Denkers EY, Gazzinelli RT.

Ciba Found Symp. 1995;195:95-104; discussion 104-9. Review.

PMID:
8724832
19.

The extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB/c mice.

Sun X, Mei M, Zhang X, Han F, Jia B, Wei X, Chang Z, Lu H, Yin J, Chen Q, Jiang N.

BMC Infect Dis. 2014 Aug 4;14:429. doi: 10.1186/1471-2334-14-429.

20.

Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.

Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H.

Vaccine. 2011 Jan 17;29(4):821-30. doi: 10.1016/j.vaccine.2010.11.002. Epub 2010 Nov 16.

PMID:
21087690

Supplemental Content

Support Center